A61K36/748

Method for isolation of polysaccharides
09951148 · 2018-04-24 · ·

The invention relates to a method for production of a preparation from a vegetable material, said preparation being enriched in a polysaccharide with a backbone comprising rhamnogalacturonan-I cores, said method comprising the steps: mixing the vegetable material with a polar alcoholic solvent; and separating a solid residue obtained in step a) from the solvent; and mixing the solid residue obtained in step b) with a buffered aqueous solution having a pH between 7 and 8. Also provided is a preparation containing rhamnogalacturonan-I pectins that can be obtained by this method and the use of such a preparation to modulate immune response.

PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF CANCER COMPRISING MIXED HERBAL EXTRACT
20250009835 · 2025-01-09 · ·

The present invention relates to an anticancer pharmaceutical composition or health functional food including a mixed extract, and specifically, including a mixed extract of Hedyotis diffusa, Prunella vulgaris, Akebia quinata, Curcuma zedoaria, and Curcumae radix. The mixed extract of the present invention is effective in inhibiting cancer cell proliferation and metastasis in various carcinomas, and thus can be usefully utilized as an anticancer pharmaceutical composition or as an anticancer health functional food.

PHARMACEUTICAL COMPOSITION AND HEALTH FUNCTIONAL FOOD FOR PREVENTION OR TREATMENT OF CANCER COMPRISING MIXED HERBAL EXTRACT
20250009835 · 2025-01-09 · ·

The present invention relates to an anticancer pharmaceutical composition or health functional food including a mixed extract, and specifically, including a mixed extract of Hedyotis diffusa, Prunella vulgaris, Akebia quinata, Curcuma zedoaria, and Curcumae radix. The mixed extract of the present invention is effective in inhibiting cancer cell proliferation and metastasis in various carcinomas, and thus can be usefully utilized as an anticancer pharmaceutical composition or as an anticancer health functional food.

Anti-tumor Traditional Chinese Medicine Microbial Fermentation Preparation And A Preparation Method And Application Thereof
20170165307 · 2017-06-15 ·

An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, ligusticum wallichii, barbat skullcap, honeysuckle flower, oldenlandia diffusa, radix trichosanthis, rhizoma anemarrhenae scutellaria baicalensis, angelica sinensis psoralea corylifolia, lucid ganoderma, and coix seed.

Anti-tumor Traditional Chinese Medicine Microbial Fermentation Preparation And A Preparation Method And Application Thereof
20170165307 · 2017-06-15 ·

An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, ligusticum wallichii, barbat skullcap, honeysuckle flower, oldenlandia diffusa, radix trichosanthis, rhizoma anemarrhenae scutellaria baicalensis, angelica sinensis psoralea corylifolia, lucid ganoderma, and coix seed.

Anti-tumor Traditional Chinese Medicine Microbial Fermentation Preparation And A Preparation Method And Application Thereof
20170165307 · 2017-06-15 ·

An anti-tumor traditional Chinese medicine, a preparation method therefor, and uses thereof. This traditional Chinese medicine is prepared by leavening of Pleurotus sp. and dioscorea bulbifera, pangolin scales, rhubarb, oyster, stiff silkworm, kelp, selfheal, ligusticum wallichii, barbat skullcap, honeysuckle flower, oldenlandia diffusa, radix trichosanthis, rhizoma anemarrhenae scutellaria baicalensis, angelica sinensis psoralea corylifolia, lucid ganoderma, and coix seed.

Herbal composition for treating metastatic breast cancer
09585927 · 2017-03-07 · ·

The invention provides a composition comprising a mixture of extracts obtained from Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophylla, and Viola philippica. The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition.

Herbal composition for treating metastatic breast cancer
09585927 · 2017-03-07 · ·

The invention provides a composition comprising a mixture of extracts obtained from Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophylla, and Viola philippica. The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition.

Herbal composition for treating metastatic breast cancer
09585927 · 2017-03-07 · ·

The invention provides a composition comprising a mixture of extracts obtained from Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophylla, and Viola philippica. The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition.

Use of cyanobacterial biomass in treating hepatitis B virus infection

Disclosed herein is the use a cyanobacterial biomass for treating hepatitis B virus (HBV) infection, in particular, chronic HBV infection. According to various embodiments of the present disclosure, the cyanobacterial biomass, upon administration of at least one month, significantly reduces the level of the surface antigen of hepatitis B virus (HBsAg) detectable in the subject receiving the treatment and/or mitigates insomnia associated with chronic HBV infection.